Last 36 quarters of trend data · Healthcare · Biotechnology
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -0.31 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 23.17 | 27.75 | 15.39 | 10.50 | 15.22 | 11.53 | 64.21 | 214.95 | 76.76 | 3753.27 | 7708.04 | 58535.65 | 25480.22 |
| — | +140.7% | -76.0% | -95.1% | -80.2% | -99.7% | -99.2% | -99.6% | -99.7% | -87.3% | -81.9% | -75.1% | +142.9% | |
| P/B Ratio | 0.79 | 1.31 | 0.77 | 0.59 | 0.75 | 0.64 | 0.70 | 1.47 | 1.00 | 12.04 | 9.78 | 3687.64 | 591.81 |
| — | +106.3% | +10.0% | -59.9% | -24.7% | -94.7% | -92.8% | -100.0% | -99.8% | -97.9% | -98.1% | +82.9% | -89.7% | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Cibus, Inc.'s operating margin was -2510.2% in Q3 2025, down 586.8 pp QoQ and up 9513.6 pp YoY. The trailing four-quarter average of -2485.3% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind. Gross margin contracted 226.7% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 100.0% | -126.7% | 100.0% | 100.0% | 100.0% | 100.0% | -106.8% | -224.2% | -64.8% | -254.5% | -268.5% | -1057.1% | -795.2% |
| — | -226.7% | +193.6% | +144.6% | +254.3% | +139.3% | +60.2% | +78.8% | +91.8% | +69.7% | +68.7% | -0.1% | -25230.1% | |
| Operating Margin | -6062.8% | -2510.2% | -1923.5% | -4020.4% | -1487.1% | -12023.8% | -2563.5% | -3385.9% | -1803.5% | -5430.9% | -9802.5% | -10626.2% | -7888.1% |
| — | +79.1% | +25.0% | -18.7% | +17.5% | -121.4% | +73.8% | +68.1% | +77.1% | +63.2% | +40.6% | +44.2% | -2184.1% | |
| Net Margin | -5898.4% | -3827.8% | -2719.4% | -4534.4% | -1906.1% | -10795.9% | -2969.3% | -4300.0% | -19684.0% | -5564.0% | -9487.3% | -12842.9% | -6754.8% |
| — | +64.5% | +8.4% | -5.5% | +90.3% | -94.0% | +68.7% | +66.5% | -191.4% | +60.7% | -56.5% | +26.9% | -1759.8% |
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -115.3% | -37.2% | -34.2% | -54.6% | -21.1% | -84.1% | -7.9% | -7.1% | -46.7% | -4.4% | -6.0% | -109.0% | -35.3% |
| — | +55.7% | -330.6% | -666.5% | +54.7% | -1831.2% | -32.5% | +93.5% | -32.2% | +91.7% | +65.4% | -181.7% | +25.1% | |
| ROA | -56.2% | -7.0% | -7.4% | -13.7% | -6.4% | -39.1% | -4.6% | -4.4% | -32.4% | -3.3% | -4.5% | -25.3% | -11.6% |
| — | +82.2% | -62.6% | -214.6% | +80.1% | -1090.4% | -2.3% | +82.8% | -180.4% | +83.8% | +36.6% | -69.8% | +37.2% | |
| ROIC | -86.2% | -17.1% | -16.9% | -30.3% | -10.9% | -62.6% | -4.8% | -4.3% | -3.3% | -3.3% | -4.7% | -20.2% | -15.0% |
| — | +72.7% | -250.9% | -610.1% | -234.4% | -1814.3% | -1.6% | +78.9% | +78.3% | +88.8% | +86.9% | +33.6% | +43.4% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
The current ratio has weakened 11.4% YoY to 1.28x, tightening the short-term liquidity position.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.37 | 0.65 | 0.48 | 0.48 | 0.37 | 0.30 | 0.24 | 0.07 | 0.07 | 0.04 | 0.04 | 5.53 | 1.92 |
| — | +114.7% | +95.8% | +574.0% | +409.6% | +581.8% | +471.2% | -98.7% | -96.2% | -97.1% | -95.8% | +484.1% | +52.0% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 0.85 | 1.28 | 1.78 | 1.23 | 0.85 | 1.44 | 1.14 | 1.23 | 1.65 | 1.37 | 2.44 | 0.61 | 2.49 |
| — | -11.4% | +55.5% | +0.1% | -48.4% | +4.8% | -53.2% | +100.7% | -33.6% | -26.8% | -14.5% | -69.3% | -20.5% | |
| Quick Ratio | 0.85 | 1.28 | 1.78 | 1.23 | 0.85 | 1.44 | 1.14 | 1.23 | 1.65 | 1.37 | 2.44 | 0.61 | 2.49 |
| — | -11.4% | +55.5% | +0.1% | -48.4% | +4.8% | -53.2% | +100.7% | -33.6% | -26.8% | -14.5% | -69.3% | -20.5% | |
| Interest Coverage | -7.56 | -1.74 | -2.07 | -4.96 | -2.19 | -22.58 | -2.46 | -2.22 | -2.44 | -3.17 | -7.38 | -185.96 | -144.04 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 36 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare performance and metrics against top competitors.
Start ComparisonCibus, Inc.'s current P/E is -0.3x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Cibus, Inc.'s current operating margin is -6062.8%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Cibus, Inc.'s business trajectory between earnings reports.